drugset / Trial / NCT02537691

Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers

NCT02537691

Phase 4 Completed 483 enrolled Hoffmann-La Roche
NaSingle-groupOpen-labelHealth-services research

Summary

Prospective, single-arm, longitudinal, international, multicenter study in a real-world cohort of adult severe asthma participants being conducted to assess the relationships between asthma biomarkers and asthma-related health-outcomes for a period of 52 weeks.

Timeline

Start
2015-08-28
Primary completion
2017-07-10
Completion
2017-07-10

Drugs

EvaluationDrugModalityDoseRoute
Background FP Unknown 500 ug Inhaled
Background Theophylline Small molecule

Indications